VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $263,022,000 | -50.4% | 18,114,432 | -16.1% | 4.45% | -54.6% |
| Q3 2016 | $530,062,000 | +21.9% | 21,591,122 | 0.0% | 9.79% | +69.2% |
| Q2 2016 | $434,845,000 | -23.4% | 21,591,122 | 0.0% | 5.79% | -9.8% |
| Q1 2016 | $567,847,000 | -66.3% | 21,591,122 | +30.1% | 6.41% | -52.6% |
| Q4 2015 | $1,686,488,000 | -51.5% | 16,591,122 | -14.8% | 13.54% | -45.6% |
| Q3 2015 | $3,473,760,000 | -19.7% | 19,473,933 | 0.0% | 24.90% | -16.8% |
| Q2 2015 | $4,326,134,000 | +11.8% | 19,473,933 | 0.0% | 29.95% | +15.9% |
| Q1 2015 | $3,867,913,000 | – | 19,473,933 | – | 25.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |